In this regard, we very much share the hopes of the authors that their discovery of a new fundamental feature of MeCP2 can further help in developing novel therapeutic approaches for RTT and other intellectual disabilities associated with MECP2 mutations. This evidence concerns the gene MECP2 and Intellectual disability.